AI that turns market complexity into commercial clarity
Anticipatory intelligence grounded in real-world data and expert insight
In today’s evolving healthcare landscape, success depends on more than access to data. It requires the ability to interpret complex, shifting markets. Pricing and policy reform, changing payer behavior, rare disease expansion, and new treatment dynamics are reshaping how therapies reach patients and why many launches fall short.
$63b
$2.23b
62%
Underperformance in year 1 due to poor early insight into patient needs, treatment gaps, and market dynamics.
Source: Trinity
Clarivate helps teams move beyond data to defensible, decision grade insight. By combining trusted data, transparent methodologies, and expert interpretation, our AI-powered solutions enable commercial, market access, and strategy teams to understand market dynamics and act with confidence.
AI purpose built for commercial decision making
As AI adoption accelerates, the difference between fast answers and decision grade insight becomes business critical. Clarivate grounds AI in expert validated data, transparent methodology, and traceable outputs — so teams can move faster without sacrificing confidence. Teams can:
Interpret true market opportunity grounded in epidemiology
Understand how access dynamics translate into real world utilization
Identify the drivers behind performance variation
Move from reactive reporting to proactive, decision led strategy
Where trusted data meets commercial AI
Optimize your commercial strategy
Make confident, defensible decisions by combining expert curated data with AI enhanced analysis.
- Validate market assumptions with traceable epidemiology and demand models
- Identify where forecasts diverge from real world behavior
- Prioritize actions based on true drivers of performance, not inferred patterns
Act earlier on access and market dynamics
Anticipate how access, payer policy, and real world behavior shape performance.
- Detect emerging payer restrictions and access barriers
- Understand where coverage fails to translate into patient starts
- Align market access, brand, and field teams around a shared, evidence based view
Connected, decision-ready commercial intelligence
Clarivate commercial AI solutions are built on proprietary datasets and expert curated intelligence across:
- Epidemiology and patient populations
- Real world claims and treatment dynamics
- Payer policy, coverage, and restrictions
- Competitive and market context
Address real world commercial challenges
Clarivate AI enhances expert-driven insight with speed and scale—helping teams reduce manual effort, focus on high-impact questions, and spend more time on strategic, judgment-driven decisions. Our approach combines:
AI Research Assistants
Natural language interfaces that surface relevant insights connected to underlying sources
AI Workflow Agents
Embedded tools that streamline analysis and highlight shifts in markets, access, and performance
Delivering impact across the commercial lifecycle
Clarivate DRG commercial AI solutions support decision-making across market assessment and forecasting, market access strategy and execution —connecting insight to action across the commercial lifecycle.
FAQs
Clarivate Life Sciences & Healthcare AI solutions for commercial teams combine curated data, transparent methodology, and expert insight to support commercial, market access, and strategy teams. These capabilities are embedded across solutions such as Disease Intelligence & Analytics, DRG Fingertip, and DRG Fusion. They are designed to help teams interpret complex market dynamics and make more confident, evidence based decisions.
Clarivate Life Sciences & Healthcare AI enhances how commercial teams access and interpret data, helping them understand market dynamics, access conditions, and real-world performance. It surfaces relevant insights, connects outputs to underlying sources, and highlights patterns in data. Final decisions remain with the user, supported by traceable evidence and expert validated intelligence.
Clarivate Life Sciences & Healthcare AI capabilities are built on proprietary and curated datasets, including epidemiology models, real world claims data, payer policy intelligence, and market context. These datasets are continuously maintained, structured through standardized taxonomies, and validated by domain experts to ensure consistency and reliability across use cases.
Clarivate applies governance practices designed to ensure transparency and trust in AI outputs. Responses are grounded in underlying data sources, with traceability built in so users can verify assumptions and context. Quality is continuously monitored through review processes and user feedback.
Clarivate continues to invest in AI capabilities across its commercial solutions, and not all innovations are embedded or deployed uniformly today. Capabilities are introduced in a phased approach, aligned to validated use cases and product readiness. This ensures that new functionality reflects real customer needs and meets the standards required for high stakes commercial decision making.
Clarivate works closely with customers to validate AI capabilities through ongoing feedback, user testing, and real world application. Customer input helps shape how solutions evolve, ensuring that outputs are relevant, interpretable, and aligned to how teams actually work. This iterative approach supports continuous improvement in both data coverage and AI enabled workflows.
Customers are at different stages in adopting and integrating AI into commercial workflows. Clarivate designs its solutions to support this range—whether teams are exploring AI, embedding it into existing processes, or scaling more advanced capabilities. Solutions are built to complement existing workflows and data strategies, allowing teams to adopt AI in a way that fits their level of maturity and operational needs.
Clarivate Life Sciences & Healthcare AI is designed to support analysis and interpretation, not to replace expert judgment or automate decisions. It provides structured insights, highlights relevant patterns, and enables faster access to evidence. Commercial decisions remain the responsibility of the user, informed by transparent data and domain expertise.
